Pridopidine improves overall mitochondrial function in cellular models of Huntington's disease

被引：0
|
作者：
Naia, L. [1 ]
Maranga, C. [1 ]
Lopes, C. [1 ]
Geva, M. [2 ,3 ]
Hayden, M. [3 ]
Cristina Rego, A. [1 ,4 ]
机构：
[1] Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Teva Pharmaceut Ind, Petah Tiqwa, Israel
[3] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[4] Univ Coimbra, Fac Med, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W2-O10
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [31] Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
    Garcia-Miralles, Marta
    Geva, Michal
    Tan, Jing Ying
    Yusof, Nur Amirah Binte Mohammad
    Cha, Yoonjeong
    Kusko, Rebecca
    Tan, Liang Juin
    Xu, Xiaohong
    Grossman, Iris
    Orbach, Aric
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    JCI INSIGHT, 2017, 2 (23)
  • [32] Pridopidine, a Highly Selective S1R Agonist for the Treatment of Huntington Disease
    Geva, Michal
    Raymond, Lynn
    Ross, Chris
    Rego, Ana Cristina
    Saudou, Frederic
    Bezprozvanny, Ilya
    Hayden, Michael
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1360 - 1361
  • [33] EVALUATION OF PRIDOPIDINE IN THE TRANSGENIC YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Miralles, Marta Garcia
    Tan, Liang Juin
    Lim, Madeline
    Geva, Michal
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A92 - A92
  • [34] Mitochondrial Dysfunction in Huntington's Disease
    Carmo, Catarina
    Naia, Luana
    Lopes, Carla
    Cristina Rego, A.
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 59 - 83
  • [35] Lipoic acid improves survival in transgenic mouse models of Huntington's disease
    Andreassen, OA
    Ferrante, RJ
    Dedeoglu, A
    Beal, MF
    NEUROREPORT, 2001, 12 (15) : 3371 - 3373
  • [36] Hydroxytyrosol improves mitochondrial energetics of a cellular model of Alzheimer's disease
    Visioli, Francesco
    Rodriguez-Perez, Maria
    Gomez-Torres, Oscar
    Pintado-Losa, Cristina
    Burgos-Ramos, Emma
    NUTRITIONAL NEUROSCIENCE, 2022, 25 (05) : 990 - 1000
  • [37] A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's Disease
    Kieburtz, Karl
    McGarry, Andrew
    McDermott, Michael
    Kayson, Elise
    Harrison, Madaline
    Marder, Karen
    Walker, Francis
    MOVEMENT DISORDERS, 2013, 28 (10) : 1407 - 1415
  • [38] VOLUNTARY EXERCISE IMPROVES CIRCADIAN FUNCTION IN A MOUSE MODEL OF HUNTINGTON'S DISEASE
    Aungier, J.
    Cuesta, M.
    Morton, A. J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A14 - A14
  • [39] PHARMACOLOGICAL MODULATION OF HSP70 IN CELLULAR MODELS OF HUNTINGTON'S DISEASE
    Reis, Sara D.
    Almeida, Liliana M.
    Pinho, Brigida R.
    Oliveira, Jorge M. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A7 - A7
  • [40] Mitochondrial function in Huntington's disease: A comparison between isolated and in situ mitochondria
    Oliveira, JM
    Jekabsons, MB
    Chen, SF
    Riley, R
    Lin, A
    Ellerby, LM
    Rego, AC
    Nicholls, DG
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
12345